Emergent BioSolutions Inc. (EBS)
NYSE: EBS · Real-Time Price · USD
12.33
+0.92 (8.06%)
At close: Dec 15, 2025, 4:00 PM EST
12.25
-0.08 (-0.65%)
After-hours: Dec 15, 2025, 7:28 PM EST

Emergent BioSolutions Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
6485181255892,3394,749
Upgrade
Market Cap Growth
18.21%315.99%-78.86%-74.81%-50.75%70.50%
Upgrade
Enterprise Value
1,0731,0449171,4142,8245,255
Upgrade
Last Close Price
12.339.562.4011.8143.4789.60
Upgrade
PE Ratio
9.13---10.6515.53
Upgrade
Forward PE
4.15--51.157.199.53
Upgrade
PS Ratio
0.840.500.120.531.323.01
Upgrade
PB Ratio
1.121.070.190.431.453.28
Upgrade
P/TBV Ratio
4.99-1.511.342.999.18
Upgrade
P/FCF Ratio
462.5514.47--24.3412.02
Upgrade
P/OCF Ratio
49.818.82--7.308.85
Upgrade
PEG Ratio
---11.760.210.68
Upgrade
EV/Sales Ratio
1.361.000.871.261.593.33
Upgrade
EV/EBITDA Ratio
4.8819.55-90.085.608.63
Upgrade
EV/EBIT Ratio
8.66---7.3210.53
Upgrade
EV/FCF Ratio
766.4829.17--29.3913.30
Upgrade
Debt / Equity Ratio
1.151.401.351.030.540.64
Upgrade
Debt / EBITDA Ratio
3.0512.66-90.851.721.50
Upgrade
Debt / FCF Ratio
479.2918.89--9.132.34
Upgrade
Asset Turnover
0.540.650.420.370.610.61
Upgrade
Inventory Turnover
1.192.292.342.383.012.70
Upgrade
Quick Ratio
2.891.560.470.662.292.22
Upgrade
Current Ratio
5.773.691.040.993.403.11
Upgrade
Return on Equity (ROE)
13.91%-33.67%-74.67%-14.11%14.35%24.12%
Upgrade
Return on Assets (ROA)
5.27%-2.03%-4.21%-2.23%8.26%11.98%
Upgrade
Return on Capital (ROIC)
6.35%-2.43%-4.84%-2.58%9.93%14.52%
Upgrade
Return on Capital Employed (ROCE)
9.40%-4.30%-14.30%-5.60%14.90%20.00%
Upgrade
Earnings Yield
11.72%-36.80%-610.73%-35.91%9.39%6.44%
Upgrade
FCF Yield
0.22%6.91%-207.11%-25.44%4.11%8.32%
Upgrade
Buyback Yield / Dilution
-6.86%-3.52%-2.20%7.39%-0.56%-2.67%
Upgrade
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q